Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiomyocyte Specific Cell Free DNA as a Marker of Cardiac Sarcoidosis

NCT03858777 is registered in ClinicalTrials.gov with Nabeel Hamzeh as lead sponsor.

NCT NCT03858777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03858777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiomyocyte Specific Cell Free DNA as a Marker of Cardiac Sarcoidosis
Lead sponsor
Nabeel Hamzeh
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2019
Completion date
June 30, 2028
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, sarcoidosis, sarcoidosis with myocarditis, st elevation myocardial infarction